QSAM Biosciences ROCE
Qual é o ROCE de QSAM Biosciences?
O ROCE de QSAM Biosciences, Inc. é 427.73%
Qual é a definição de ROCE?
O retorno sobre o capital empregado (ROCE) é um índice financeiro que mede a lucratividade de uma empresa e a eficiência com que seu capital é usado.
Return on capital employed (ROCE) is the total amount of capital that a company has utilized in order to generate profits. It is the sum of shareholders' equity and debt liabilities. It can be simplified as total assets minus current liabilities.
ROCE is especially useful when comparing the performance of companies in capital-intensive sectors. ROCE considers debt and other liabilities as well compared to other fundamentals which only analyze profitability related to a company’s common equity. This provides a better indication of financial performance for companies with significant debt. For a company, the ROCE trend over the years is also an important indicator of performance. In general, investors tend to favor companies with stable and rising ROCE numbers over companies where ROCE is volatile and bounces around from one year to the next.
Instead of using capital employed at an arbitrary point in time, analysts and investors often calculate ROCE based on the average capital employed (ROACE), which takes the average of opening and closing capital employed for the time period.
ROCE de empresas na Setor Health Care em OTC em comparação com QSAM Biosciences
O que QSAM Biosciences faz?
QSAM Biosciences, Inc., a clinical stage biotechnology company, develops drugs for the treatment of bone cancer. The company is involved in the development of CycloSam (Samaium-153 DOTMP), a clinical-stage novel radiopharmaceutical for the treatment of bone cancer and related diseases. It has a license agreement with IGL Pharma, Inc. The company was formerly known as Q2Earth, Inc. and changed its name to QSAM Biosciences, Inc. in September 2020. QSAM Biosciences, Inc. was founded in 2004 and is based in Austin, Texas.
Empresas com roce semelhantes a QSAM Biosciences
- PAVmed Inc tem ROCE de 411.68%
- Q-Gold Resources tem ROCE de 414.05%
- LiteLink Technologies tem ROCE de 414.08%
- Empire Industries tem ROCE de 418.52%
- 102570 tem ROCE de 421.84%
- Capitan Mining tem ROCE de 423.79%
- QSAM Biosciences tem ROCE de 427.73%
- Mustang Bio Inc tem ROCE de 433.01%
- Sonoro Gold tem ROCE de 434.69%
- Nevtah Capital Management tem ROCE de 448.86%
- Richland Resources International tem ROCE de 448.86%
- Permian Basin Royalty Trust tem ROCE de 457.43%
- Navigator Acquisition tem ROCE de 463.12%